Black Diamond Therapeutics/$BDTX
About Black Diamond Therapeutics
Ticker
Industry
Employees
BDTX Metrics
$124M
-
-$1.36
2.52
-
Price and volume
Market cap
$124M
Beta
2.52
52-week high
$7.66
52-week low
$1.91
Average daily volume
952K
Financial strength
Current ratio
5.555
Quick ratio
5.417
Long term debt to equity
20.19
Total debt to equity
23.607
Management effectiveness
Return on assets (TTM)
-32.78%
Return on equity (TTM)
-63.09%
Valuation
Price to book
1.28
Price to tangible book (TTM)
1.28
Price to free cash flow (TTM)
-1.934
Growth
Earnings per share change (TTM)
-35.19%
3-year earnings per share growth (CAGR)
-26.28%
What the Analysts think about BDTX
Analyst Ratings
BDTX Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
BDTX Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
BDTX News
Black Diamond Therapeutics: Speculative Buy With Precision Oncology Catalysts
Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
What’s the current market cap for Black Diamond Therapeutics stock?
What is the P/E ratio for Black Diamond Therapeutics stock?
Does Black Diamond Therapeutics stock pay dividends?
No, Black Diamond Therapeutics (BDTX) stock does not pay dividends to its shareholders as of January 21, 2025.
When is the next Black Diamond Therapeutics dividend payment date?
Black Diamond Therapeutics (BDTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Black Diamond Therapeutics?
Black Diamond Therapeutics (BDTX) has a beta rating of 2.52. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.